n/a
Article Publish Status: FREE
Abstract Title:

Why we need a clinical trial for vitamin K.

Abstract Source:

BMJ. 1994 Apr 2 ;308(6933):908-10. PMID: 8173376

Abstract Author(s):

J M Slattery

Article Affiliation:

J M Slattery

Abstract:

Vitamin K is given to many babies born in the United Kingdom, but we still do not know if it has substantial hazards. Because the population exposed to vitamin K is very large even quite small hazards would involve many adverse events. It is therefore important to be able to put reasonably close bounds on the potential damage that vitamin K prophylaxis could cause. Past research has not allowed us to do this but a large randomised controlled clinical trial of vitamin K against no vitamin K, enrolling only infants at low risk of haemorrhagic disease, would do so. There is no question that vitamin K is a useful treatment in babies at highest risk of haemorrhagic disease: the question is whether the trend towards use of vitamin K in lower risk babies should be encouraged.

Study Type : Review
Additional Links
Diseases : Cancers
Anti Therapeutic Actions : Vitamin K injections : CK(78) : AC(19)

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.